{"id":"ccb-use","safety":{"commonSideEffects":[{"rate":"null","effect":"Edema"},{"rate":"null","effect":"Dizziness"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This results in decreased peripheral resistance, reduced blood pressure, and a decrease in cardiac workload, which can help alleviate symptoms of hypertension and angina. CCBs can also have a negative inotropic effect, which can be beneficial in certain cardiac conditions.","oneSentence":"CCBs work by inhibiting the L-type calcium channels in the heart and vascular smooth muscle, leading to vasodilation and reduced cardiac workload.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:49:58.238Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"}]},"trialDetails":[{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":"Diabetes Mellitus, High Blood Pressure, Cardiovascular Diseases","enrollment":9476},{"nctId":"NCT05081999","phase":"PHASE4","title":"De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-01-30","conditions":"Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy","enrollment":59},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07447297","phase":"NA","title":"Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2024-01-02","conditions":"Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter","enrollment":520},{"nctId":"NCT07445334","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","status":"NOT_YET_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2026-03-01","conditions":"Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats","enrollment":40},{"nctId":"NCT07246629","phase":"PHASE4","title":"Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-04","conditions":"Subarachnoid Hemorrhage","enrollment":214},{"nctId":"NCT07272902","phase":"NA","title":"Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2026-01-01","conditions":"Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":84},{"nctId":"NCT07099677","phase":"NA","title":"Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk","status":"RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2025-08-01","conditions":"Hypertension, Fall Risk, Postural Balance","enrollment":186},{"nctId":"NCT03461874","phase":"NA","title":"ACT Therapy for HF Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-03-15","conditions":"Migraine Without Aura","enrollment":64},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT05780710","phase":"NA","title":"OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake","status":"RECRUITING","sponsor":"Aktiia SA","startDate":"2023-06-29","conditions":"Hypertension","enrollment":35},{"nctId":"NCT04434664","phase":"PHASE4","title":"BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-12-01","conditions":"Heart Failure With Preserved Ejection Fraction, Hypertension","enrollment":50},{"nctId":"NCT07313605","phase":"PHASE1, PHASE2","title":"POCUS-Guided Esmolol in Septic Shock: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"John Basmaji","startDate":"2026-01-15","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT07291375","phase":"EARLY_PHASE1","title":"Role of Amlodipine in Reduction of CIN","status":"NOT_YET_RECRUITING","sponsor":"Minia University","startDate":"2025-12-20","conditions":"Contrast-induced Nephropathy","enrollment":40},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT05786417","phase":"PHASE4","title":"LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-05-10","conditions":"Angina, Stable Ischemic Heart Disease","enrollment":741},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT07241338","phase":"PHASE4","title":"Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity","status":"NOT_YET_RECRUITING","sponsor":"Jing Liu","startDate":"2025-11","conditions":"Hypertension","enrollment":104},{"nctId":"NCT05049616","phase":"PHASE4","title":"Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-10-18","conditions":"Hypertension in Pregnancy, Postpartum Preeclampsia","enrollment":70},{"nctId":"NCT06730945","phase":"PHASE4","title":"Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG","status":"WITHDRAWN","sponsor":"Ruijin Hospital","startDate":"2025-06","conditions":"Coronary Artery Bypass Graft Surgery (CABG), Radial Artery Grafts, Graft Failure","enrollment":""},{"nctId":"NCT04753840","phase":"NA","title":"Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2021-07-03","conditions":"Hypertension","enrollment":90},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT06699342","phase":"NA","title":"Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-01-27","conditions":"Atrial Fibrillation (AF)","enrollment":50},{"nctId":"NCT00540787","phase":"PHASE4","title":"A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Biosense Webster, Inc.","startDate":"2003-08-01","conditions":"Paroxysmal Atrial Fibrillation","enrollment":112},{"nctId":"NCT01570361","phase":"PHASE4","title":"Atrial Fibrillation Progression Trial","status":"TERMINATED","sponsor":"Biosense Webster, Inc.","startDate":"2012-02-13","conditions":"Atrial Fibrillation","enrollment":255},{"nctId":"NCT05130268","phase":"PHASE4","title":"Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation","status":"COMPLETED","sponsor":"American Heart Association","startDate":"2021-10-29","conditions":"Atrial Fibrillation","enrollment":339},{"nctId":"NCT05410860","phase":"PHASE3","title":"Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia","status":"COMPLETED","sponsor":"Corxel Pharmaceuticals","startDate":"2022-06-30","conditions":"Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia","enrollment":500},{"nctId":"NCT06711432","phase":"NA","title":"Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-09-18","conditions":"Tumor, Stroke","enrollment":214},{"nctId":"NCT05625503","phase":"EARLY_PHASE1","title":"Dilution of Verapamil During Intraarterial Administration","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2022-12-13","conditions":"Vasospasm;Peripheral, Burning, Pain","enrollment":55},{"nctId":"NCT03635996","phase":"PHASE3","title":"Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302","status":"TERMINATED","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2018-12-10","conditions":"Paroxysmal Supraventricular Tachycardia","enrollment":169},{"nctId":"NCT02459574","phase":"NA","title":"Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-05-01","conditions":"Heart Failure, Recurrent Atrial Fibrillation","enrollment":321},{"nctId":"NCT06626607","phase":"","title":"Different Antihypertensive Drugs on Aortic Diseases","status":"COMPLETED","sponsor":"Eighth Affiliated Hospital, Sun Yat-sen University","startDate":"2017-01-01","conditions":"Aortic Aneurysm, Aortic Dissection","enrollment":704},{"nctId":"NCT05972785","phase":"","title":"Long-term Use of CCB and Breast Cancer Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Curtin University","startDate":"2022-07-01","conditions":"Hypertension,Essential, Breast Cancer","enrollment":68500},{"nctId":"NCT06563297","phase":"PHASE4","title":"To Explore the Optimal Dose of Alfentanil for Skull Pin Fixation in Intracranial Surgery","status":"NOT_YET_RECRUITING","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2024-08-13","conditions":"Procedural Pain","enrollment":40},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT03464019","phase":"PHASE3","title":"Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).","status":"TERMINATED","sponsor":"Milestone Pharmaceuticals Inc.","startDate":"2018-06-18","conditions":"Paroxysmal Supraventricular Tachycardia","enrollment":1097},{"nctId":"NCT04647292","phase":"PHASE2","title":"European Blood Pressure Intensive Control After Stroke","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2024-05-02","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":142},{"nctId":"NCT00739674","phase":"PHASE3","title":"SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02-01","conditions":"Hypertension","enrollment":992},{"nctId":"NCT06395194","phase":"PHASE3","title":"Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"1997-09-27","conditions":"Essential Hypertension","enrollment":15313},{"nctId":"NCT05818995","phase":"","title":"Therapeutic Drug Use for CKD Patients","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2022-07-01","conditions":"Chronic Kidney Disease","enrollment":10000},{"nctId":"NCT06274255","phase":"","title":"Serum Magnesium Level and Pediatric Migraine","status":"UNKNOWN","sponsor":"Mersin University","startDate":"2024-03-01","conditions":"Migraine, Magnesium, Pediatric","enrollment":60},{"nctId":"NCT06265415","phase":"NA","title":"Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-03-30","conditions":"Severe Preeclampsia","enrollment":60},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT04030234","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-09-17","conditions":"Hypertension","enrollment":11255},{"nctId":"NCT04036409","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients","status":"UNKNOWN","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-05","conditions":"Ischemic Stroke, Blood Pressure, Cognitive Impairment","enrollment":4369},{"nctId":"NCT06176599","phase":"NA","title":"Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis","status":"UNKNOWN","sponsor":"Lin Liao","startDate":"2022-09-01","conditions":"Diabetic Kidney Disease","enrollment":60},{"nctId":"NCT01421771","phase":"NA","title":"Blood Pressure in Dialysis Patients","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2011-10","conditions":"Hypertension, Renal Failure Chronic Requiring Hemodialysis, Blood Pressure","enrollment":126},{"nctId":"NCT04606459","phase":"NA","title":"COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina","status":"RECRUITING","sponsor":"Johannes Gutenberg University Mainz","startDate":"2021-04-01","conditions":"Coronary Microvascular Disease, Refractory Angina","enrollment":144},{"nctId":"NCT05905848","phase":"PHASE3","title":"Pre-operative Antihypertension Strategies-Carotid Artery Stenting","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2023-06-15","conditions":"Carotid Stenosis","enrollment":560},{"nctId":"NCT04777045","phase":"PHASE3","title":"Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2019-10-25","conditions":"Microvascular Angina, Coronary Vasospasm, Microvascular Ischemia of Myocardium","enrollment":85},{"nctId":"NCT05745337","phase":"PHASE1","title":"Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor","status":"UNKNOWN","sponsor":"University of Vermont","startDate":"2023-02-06","conditions":"Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":20},{"nctId":"NCT03261375","phase":"NA","title":"To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension","status":"COMPLETED","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2021-01-19","conditions":"Hypertension","enrollment":205},{"nctId":"NCT05352633","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-07-18","conditions":"Blood Pressure","enrollment":710},{"nctId":"NCT05294887","phase":"PHASE4","title":"Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2022-03-04","conditions":"Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary","enrollment":132},{"nctId":"NCT02913664","phase":"PHASE2, PHASE3","title":"Risk Reduction for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2017-02-02","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":513},{"nctId":"NCT02695992","phase":"PHASE4","title":"Rate Control in Atrial Fibrillation II","status":"COMPLETED","sponsor":"Asker & Baerum Hospital","startDate":"2016-02","conditions":"Atrial Fibrillation, Permanent Atrial Fibrillation","enrollment":122},{"nctId":"NCT04234477","phase":"PHASE4","title":"Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)","status":"WITHDRAWN","sponsor":"Boston University","startDate":"2021-12","conditions":"Atrial Fibrillation","enrollment":""},{"nctId":"NCT02774460","phase":"PHASE4","title":"The Precision Hypertension Care Study","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2017-02-20","conditions":"Hypertension","enrollment":280},{"nctId":"NCT04942171","phase":"NA","title":"EMOTIon and COgNitive Function After Atrial Fibrillation Catheter Ablation vs. Medical Therapy(EMOTICON Trial)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2021-06","conditions":"Atrial Fibrillation","enrollment":320},{"nctId":"NCT02391337","phase":"PHASE4","title":"Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)","status":"COMPLETED","sponsor":"University of Birmingham","startDate":"2016-12-20","conditions":"Permanent Atrial Fibrillation","enrollment":161},{"nctId":"NCT03722524","phase":"","title":"The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension","status":"COMPLETED","sponsor":"Servier Russia","startDate":"2018-10-01","conditions":"Arterial Hypertension","enrollment":1247},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT00294567","phase":"PHASE4","title":"Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)","status":"COMPLETED","sponsor":"Juntendo University","startDate":"2005-12","conditions":"Hypertension, Coronary Atherosclerosis","enrollment":199},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT04846621","phase":"PHASE2","title":"Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-06-01","conditions":"Preterm Labor With Preterm Delivery","enrollment":230},{"nctId":"NCT03877783","phase":"NA","title":"DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Umeå University","startDate":"2020-10-19","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":10},{"nctId":"NCT01206062","phase":"NA","title":"Systolic Blood Pressure Intervention Trial","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-10","conditions":"Hypertension","enrollment":9361},{"nctId":"NCT02642146","phase":"","title":"Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study","status":"TERMINATED","sponsor":"Seoul National University Hospital","startDate":"2015-01","conditions":"Raynaud Disease, Systemic Sclerosis, Digital Ulcer","enrollment":71},{"nctId":"NCT04572724","phase":"PHASE4","title":"The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value","status":"UNKNOWN","sponsor":"Shenzhen Second People's Hospital","startDate":"2020-07-06","conditions":"Peritoneal Dialysis Complication, Hemodialysis Complication, Heart Failure","enrollment":120},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT04434365","phase":"PHASE1, PHASE2","title":"Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-06-21","conditions":"Stable Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":24},{"nctId":"NCT04379310","phase":"","title":"Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)","status":"COMPLETED","sponsor":"Istanbul Nisantasi University","startDate":"2020-05-01","conditions":"Covid-19","enrollment":54},{"nctId":"NCT00283686","phase":"PHASE3","title":"HALT Progression of Polycystic Kidney Disease Study A","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-01","conditions":"Kidney, Polycystic","enrollment":558},{"nctId":"NCT04216706","phase":"","title":"Early Vascular Adjustments to Prevent Preeclampsia","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2014-11-01","conditions":"Preeclampsia, Small for Gestational Age at Delivery, HELLP Syndrome","enrollment":314},{"nctId":"NCT04017845","phase":"EARLY_PHASE1","title":"Screening for Colorectal Cancer in Average and High Risk Population","status":"COMPLETED","sponsor":"Lewai Sharki Abdulaziz, MSc PhD","startDate":"2015-04-01","conditions":"Colorectal Neoplasms, Colorectal Cancer, Adenomatous Polyp of Colon","enrollment":537},{"nctId":"NCT01760083","phase":"NA","title":"A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions","status":"COMPLETED","sponsor":"Euro CTO Club","startDate":"2013-01","conditions":"Chronic Stable Angina, Dyspnea, Coronary Occlusion","enrollment":450},{"nctId":"NCT02744456","phase":"EARLY_PHASE1","title":"N-of-1 Trials for Blood Pressure Medications in Adults","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-08-01","conditions":"Hypertension, High Blood Pressure","enrollment":10},{"nctId":"NCT02132767","phase":"PHASE3","title":"Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-05","conditions":"Postoperative Atrial Fibrillation","enrollment":523},{"nctId":"NCT01551368","phase":"PHASE2","title":"Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2012-12","conditions":"Infertility","enrollment":12},{"nctId":"NCT02412761","phase":"NA","title":"Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-06","conditions":"Essential Hypertension","enrollment":42},{"nctId":"NCT02591004","phase":"PHASE2, PHASE3","title":"Calcium Channel Blockers Compared to Magnesium Sulfate in Fetal Cerebral Blood Flow","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2015-12","conditions":"Preterm Labor, Cerebral Palsy","enrollment":130},{"nctId":"NCT01359514","phase":"NA","title":"Mechanism-based Choice of Therapy for Neuropathic Pain","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2008-04","conditions":"Pain","enrollment":32},{"nctId":"NCT03298191","phase":"PHASE4","title":"Tocolysis in Prevention of Preterm Labor","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-25","conditions":"Preterm Labor Without Delivery","enrollment":300},{"nctId":"NCT03228238","phase":"PHASE4","title":"ANti-Oxidant in Variant Angina (ANOVA) Trial","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2014-09-01","conditions":"Variant Angina","enrollment":300},{"nctId":"NCT00413712","phase":"PHASE4","title":"Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"1997-01","conditions":"Supraventricular Tachycardia","enrollment":206},{"nctId":"NCT01994408","phase":"PHASE1, PHASE2","title":"Default BP Medication Intensification","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2013-11","conditions":"Hypertension","enrollment":3},{"nctId":"NCT03033537","phase":"","title":"Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction","status":"COMPLETED","sponsor":"Adam International Hospital","startDate":"2015-07-01","conditions":"Erectile Dysfunction","enrollment":20},{"nctId":"NCT01167920","phase":"NA","title":"Virtual Hypertension Clinic","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2009-11","conditions":"Hypertension","enrollment":74},{"nctId":"NCT02474420","phase":"NA","title":"Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients","status":"UNKNOWN","sponsor":"Kevin H.M. Kuo, MD, MSc, FRCPC","startDate":"2015-06","conditions":"Beta-Thalassemia, Iron Overload","enrollment":60},{"nctId":"NCT01896661","phase":"PHASE3","title":"Effect of Antihypertensive Agents Over Sleep Apnea","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-12","conditions":"Hypertension, Obstructive Sleep Apnea","enrollment":53},{"nctId":"NCT02419534","phase":"PHASE4","title":"Pediatrics Anal Fissures Treatment With Polyethylene Glycol","status":"UNKNOWN","sponsor":"King Saud University","startDate":"2014-11","conditions":"Fissure in Ano","enrollment":46},{"nctId":"NCT00006305","phase":"PHASE3","title":"Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2000-09","conditions":"Coronary Disease, Cardiovascular Diseases, Heart Diseases","enrollment":2368},{"nctId":"NCT01089452","phase":"PHASE4","title":"Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study","status":"WITHDRAWN","sponsor":"Monash University","startDate":"","conditions":"Hypertension","enrollment":""},{"nctId":"NCT01028534","phase":"NA","title":"Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)","status":"COMPLETED","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2010-07","conditions":"Obstructive Sleep Apnea, Hypertension","enrollment":150},{"nctId":"NCT01587742","phase":"","title":"IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-11","conditions":"Hypertension","enrollment":1},{"nctId":"NCT02319161","phase":"","title":"Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia","status":"COMPLETED","sponsor":"Ankara University","startDate":"2014-06","conditions":"Hypertension","enrollment":50},{"nctId":"NCT01675362","phase":"PHASE4","title":"Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2012-08","conditions":"Kidney Calculi","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CCB use","genericName":"CCB use","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CCBs work by inhibiting the L-type calcium channels in the heart and vascular smooth muscle, leading to vasodilation and reduced cardiac workload. Used for Hypertension, Angina pectoris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}